PTX prescient therapeutics limited

Ann: June 2023 Quarterly Update and Appendix 4C, page-8

  1. 8,360 Posts.
    lightbulb Created with Sketch. 3680
    Hmmm, "Prescient has decided to discontinue the latter program at this stage, and thanks MD Anderson for its work. Both parties may seek to revisit the collaboration or consider other opportunities in the future."

    Perhaps juggling that extra variable of an intracellular antigen target was going to cost too much to investigate thoroughly.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.4¢
Change
0.002(4.76%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.4¢ 4.2¢ $31.46K 729.3K

Buyers (Bids)

No. Vol. Price($)
1 21345 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 535972 5
View Market Depth
Last trade - 11.57am 16/07/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.